nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—Beta5 beta6 beta7 and beta8 integrin cell surface interactions—FBN1—systemic scleroderma	0.0256	0.0959	CbGpPWpGaD
Amiloride—PLAU—endothelium—systemic scleroderma	0.0221	0.103	CbGeAlD
Amiloride—PLAU—blood vessel—systemic scleroderma	0.0204	0.0952	CbGeAlD
Amiloride—PLAU—Beta2 integrin cell surface interactions—TGFBI—systemic scleroderma	0.0146	0.0548	CbGpPWpGaD
Amiloride—ASIC2—tendon—systemic scleroderma	0.0125	0.0584	CbGeAlD
Amiloride—PLAU—amb2 Integrin signaling—SELP—systemic scleroderma	0.0123	0.0459	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—FBN1—systemic scleroderma	0.0122	0.0456	CbGpPWpGaD
Amiloride—AOC1—connective tissue—systemic scleroderma	0.0115	0.0537	CbGeAlD
Amiloride—SLC9A1—connective tissue—systemic scleroderma	0.011	0.0515	CbGeAlD
Amiloride—PLAU—Beta3 integrin cell surface interactions—TGFBI—systemic scleroderma	0.0107	0.04	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—ITGAM—systemic scleroderma	0.0106	0.0397	CbGpPWpGaD
Amiloride—PLAU—connective tissue—systemic scleroderma	0.0105	0.0488	CbGeAlD
Amiloride—SLC9A1—smooth muscle tissue—systemic scleroderma	0.0101	0.0471	CbGeAlD
Amiloride—SLC9A1—skin of body—systemic scleroderma	0.00997	0.0465	CbGeAlD
Amiloride—PLAU—amb2 Integrin signaling—ITGAM—systemic scleroderma	0.00979	0.0367	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.0096	0.036	CbGpPWpGaD
Amiloride—PLAU—smooth muscle tissue—systemic scleroderma	0.00958	0.0446	CbGeAlD
Amiloride—PLAU—skin of body—systemic scleroderma	0.00945	0.0441	CbGeAlD
Amiloride—PLAU—Beta1 integrin cell surface interactions—FBN1—systemic scleroderma	0.00864	0.0324	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—COL1A2—systemic scleroderma	0.00852	0.0319	CbGpPWpGaD
Amiloride—AOC1—digestive system—systemic scleroderma	0.00833	0.0388	CbGeAlD
Amiloride—PLAU—amb2 Integrin signaling—CTGF—systemic scleroderma	0.00817	0.0306	CbGpPWpGaD
Amiloride—SLC9A1—digestive system—systemic scleroderma	0.00798	0.0372	CbGeAlD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGAM—systemic scleroderma	0.00788	0.0295	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—TGFBI—systemic scleroderma	0.00758	0.0284	CbGpPWpGaD
Amiloride—PLAU—digestive system—systemic scleroderma	0.00756	0.0352	CbGeAlD
Amiloride—PLAU—tendon—systemic scleroderma	0.0072	0.0335	CbGeAlD
Amiloride—SCNN1G—lung—systemic scleroderma	0.00709	0.033	CbGeAlD
Amiloride—SCNN1D—lung—systemic scleroderma	0.00709	0.033	CbGeAlD
Amiloride—SLC9A1—Endothelins—COL1A2—systemic scleroderma	0.00695	0.0261	CbGpPWpGaD
Amiloride—SLC9A1—lung—systemic scleroderma	0.00666	0.0311	CbGeAlD
Amiloride—SCNN1A—digestive system—systemic scleroderma	0.00662	0.0309	CbGeAlD
Amiloride—PLAU—lung—systemic scleroderma	0.00632	0.0294	CbGeAlD
Amiloride—PLAU—Beta2 integrin cell surface interactions—CD40LG—systemic scleroderma	0.00625	0.0234	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—COL1A2—systemic scleroderma	0.00604	0.0227	CbGpPWpGaD
Amiloride—SCNN1B—lung—systemic scleroderma	0.00599	0.0279	CbGeAlD
Amiloride—PLAU—Osteopontin Signaling—MMP9—systemic scleroderma	0.00587	0.022	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—COL1A2—systemic scleroderma	0.00577	0.0216	CbGpPWpGaD
Amiloride—SCNN1A—lung—systemic scleroderma	0.00553	0.0258	CbGeAlD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.00437	0.0164	CbGpPWpGaD
Amiloride—SLC9A1—Defective B3GAT3 causes JDSSDHD—HSPG2—systemic scleroderma	0.00418	0.0157	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IRF5—systemic scleroderma	0.00396	0.0148	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MMP2—systemic scleroderma	0.0039	0.0146	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Mometasone—systemic scleroderma	0.00383	0.324	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Mometasone—systemic scleroderma	0.00383	0.324	CbGdCrCtD
Amiloride—PLAU—amb2 Integrin signaling—MMP2—systemic scleroderma	0.0038	0.0142	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—EDN1—systemic scleroderma	0.00377	0.0141	CbGpPWpGaD
Amiloride—SLC22A2—digestive system—systemic scleroderma	0.00358	0.0167	CbGeAlD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.00355	0.0133	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.00338	0.0127	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—CSK—systemic scleroderma	0.00337	0.0126	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—systemic scleroderma	0.00317	0.0119	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—MMP1—systemic scleroderma	0.00316	0.0119	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—EDN1—systemic scleroderma	0.00312	0.0117	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MMP9—systemic scleroderma	0.00293	0.011	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—MMP9—systemic scleroderma	0.00285	0.0107	CbGpPWpGaD
Amiloride—SLC22A4—digestive system—systemic scleroderma	0.00265	0.0124	CbGeAlD
Amiloride—PLAU—AP-1 transcription factor network—MMP1—systemic scleroderma	0.00262	0.00983	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.00254	0.00952	CbGpPWpGaD
Amiloride—SLC22A4—tendon—systemic scleroderma	0.00252	0.0118	CbGeAlD
Amiloride—PLAU—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.00233	0.00872	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—systemic scleroderma	0.0023	0.00861	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—HSPG2—systemic scleroderma	0.00224	0.00841	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1A—systemic scleroderma	0.00224	0.00841	CbGpPWpGaD
Amiloride—SLC22A4—lung—systemic scleroderma	0.00222	0.0103	CbGeAlD
Amiloride—PLAU—AP-1 transcription factor network—CCL2—systemic scleroderma	0.00213	0.008	CbGpPWpGaD
Amiloride—PLAU—Betamethasone—Prednisone—systemic scleroderma	0.00209	0.176	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Prednisone—systemic scleroderma	0.00209	0.176	CbGdCrCtD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—systemic scleroderma	0.00189	0.00709	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—MMP9—systemic scleroderma	0.00188	0.00704	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—MMP9—systemic scleroderma	0.00164	0.00614	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—MMP9—systemic scleroderma	0.00153	0.00572	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—TGFB1—systemic scleroderma	0.00135	0.00506	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SELP—systemic scleroderma	0.00135	0.00504	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TGFB1—systemic scleroderma	0.00126	0.00471	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RHOB—systemic scleroderma	0.00126	0.00471	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1B—systemic scleroderma	0.00117	0.00439	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CSK—systemic scleroderma	0.00114	0.00429	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ITGAM—systemic scleroderma	0.00108	0.00403	CbGpPWpGaD
Amiloride—Alopecia—Lisinopril—systemic scleroderma	0.000955	0.00188	CcSEcCtD
Amiloride—Dyspepsia—Captopril—systemic scleroderma	0.000954	0.00188	CcSEcCtD
Amiloride—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000951	0.00188	CcSEcCtD
Amiloride—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000947	0.00187	CcSEcCtD
Amiloride—Dizziness—Pentoxifylline—systemic scleroderma	0.000946	0.00187	CcSEcCtD
Amiloride—Decreased appetite—Captopril—systemic scleroderma	0.000942	0.00186	CcSEcCtD
Amiloride—Vertigo—Mycophenolic acid—systemic scleroderma	0.000938	0.00185	CcSEcCtD
Amiloride—Fatigue—Captopril—systemic scleroderma	0.000934	0.00184	CcSEcCtD
Amiloride—Arthralgia—Leflunomide—systemic scleroderma	0.000932	0.00184	CcSEcCtD
Amiloride—Chest pain—Leflunomide—systemic scleroderma	0.000932	0.00184	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000928	0.00183	CcSEcCtD
Amiloride—Constipation—Captopril—systemic scleroderma	0.000927	0.00183	CcSEcCtD
Amiloride—Flatulence—Lisinopril—systemic scleroderma	0.000927	0.00183	CcSEcCtD
Amiloride—Tension—Lisinopril—systemic scleroderma	0.000923	0.00182	CcSEcCtD
Amiloride—Palpitations—Mycophenolic acid—systemic scleroderma	0.000923	0.00182	CcSEcCtD
Amiloride—Nervousness—Lisinopril—systemic scleroderma	0.000913	0.0018	CcSEcCtD
Amiloride—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000912	0.0018	CcSEcCtD
Amiloride—Cough—Mycophenolic acid—systemic scleroderma	0.000911	0.0018	CcSEcCtD
Amiloride—Back pain—Lisinopril—systemic scleroderma	0.00091	0.0018	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	0.000909	0.00341	CbGpPWpGaD
Amiloride—Vomiting—Pentoxifylline—systemic scleroderma	0.000909	0.00179	CcSEcCtD
Amiloride—Muscle spasms—Lisinopril—systemic scleroderma	0.000904	0.00178	CcSEcCtD
Amiloride—Rash—Pentoxifylline—systemic scleroderma	0.000902	0.00178	CcSEcCtD
Amiloride—Dermatitis—Pentoxifylline—systemic scleroderma	0.000901	0.00178	CcSEcCtD
Amiloride—Headache—Pentoxifylline—systemic scleroderma	0.000896	0.00177	CcSEcCtD
Amiloride—Feeling abnormal—Captopril—systemic scleroderma	0.000893	0.00176	CcSEcCtD
Amiloride—Chest pain—Mycophenolic acid—systemic scleroderma	0.000889	0.00175	CcSEcCtD
Amiloride—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000889	0.00175	CcSEcCtD
Amiloride—Gastrointestinal pain—Captopril—systemic scleroderma	0.000886	0.00175	CcSEcCtD
Amiloride—Asthenia—Mometasone—systemic scleroderma	0.000885	0.00175	CcSEcCtD
Amiloride—Polyuria—Methotrexate—systemic scleroderma	0.000883	0.00174	CcSEcCtD
Amiloride—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000883	0.00174	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TGFB1—systemic scleroderma	0.000883	0.00331	CbGpPWpGaD
Amiloride—Tremor—Lisinopril—systemic scleroderma	0.000881	0.00174	CcSEcCtD
Amiloride—Pruritus—Mometasone—systemic scleroderma	0.000873	0.00172	CcSEcCtD
Amiloride—SLC9A1—Disease—SMAD7—systemic scleroderma	0.000872	0.00327	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000862	0.0017	CcSEcCtD
Amiloride—Confusional state—Mycophenolic acid—systemic scleroderma	0.000859	0.0017	CcSEcCtD
Amiloride—Abdominal pain—Captopril—systemic scleroderma	0.000857	0.00169	CcSEcCtD
Amiloride—Anorexia—Leflunomide—systemic scleroderma	0.000852	0.00168	CcSEcCtD
Amiloride—Nausea—Pentoxifylline—systemic scleroderma	0.00085	0.00168	CcSEcCtD
Amiloride—Vertigo—Lisinopril—systemic scleroderma	0.000845	0.00167	CcSEcCtD
Amiloride—Diarrhoea—Mometasone—systemic scleroderma	0.000844	0.00167	CcSEcCtD
Amiloride—Shock—Mycophenolic acid—systemic scleroderma	0.000838	0.00165	CcSEcCtD
Amiloride—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000836	0.00165	CcSEcCtD
Amiloride—Palpitations—Lisinopril—systemic scleroderma	0.000831	0.00164	CcSEcCtD
Amiloride—Cough—Lisinopril—systemic scleroderma	0.000821	0.00162	CcSEcCtD
Amiloride—Muscular weakness—Prednisone—systemic scleroderma	0.000818	0.00161	CcSEcCtD
Amiloride—Visual disturbance—Methotrexate—systemic scleroderma	0.000818	0.00161	CcSEcCtD
Amiloride—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000817	0.00161	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000814	0.00161	CcSEcCtD
Amiloride—Anorexia—Mycophenolic acid—systemic scleroderma	0.000812	0.0016	CcSEcCtD
Amiloride—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000812	0.0016	CcSEcCtD
Amiloride—Tension—Mycophenolate mofetil—systemic scleroderma	0.000809	0.0016	CcSEcCtD
Amiloride—Insomnia—Leflunomide—systemic scleroderma	0.000808	0.00159	CcSEcCtD
Amiloride—Abdominal distension—Prednisone—systemic scleroderma	0.000807	0.00159	CcSEcCtD
Amiloride—Paraesthesia—Leflunomide—systemic scleroderma	0.000802	0.00158	CcSEcCtD
Amiloride—Arthralgia—Lisinopril—systemic scleroderma	0.000801	0.00158	CcSEcCtD
Amiloride—Chest pain—Lisinopril—systemic scleroderma	0.000801	0.00158	CcSEcCtD
Amiloride—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.0008	0.00158	CcSEcCtD
Amiloride—SLC9A1—Disease—TGFBI—systemic scleroderma	0.000797	0.00299	CbGpPWpGaD
Amiloride—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000797	0.00157	CcSEcCtD
Amiloride—Dyspnoea—Leflunomide—systemic scleroderma	0.000796	0.00157	CcSEcCtD
Amiloride—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000792	0.00156	CcSEcCtD
Amiloride—Dyspepsia—Leflunomide—systemic scleroderma	0.000786	0.00155	CcSEcCtD
Amiloride—Vomiting—Mometasone—systemic scleroderma	0.000785	0.00155	CcSEcCtD
Amiloride—Feeling abnormal—Azathioprine—systemic scleroderma	0.000779	0.00154	CcSEcCtD
Amiloride—Rash—Mometasone—systemic scleroderma	0.000778	0.00154	CcSEcCtD
Amiloride—Asthenia—Captopril—systemic scleroderma	0.000778	0.00153	CcSEcCtD
Amiloride—Dermatitis—Mometasone—systemic scleroderma	0.000777	0.00153	CcSEcCtD
Amiloride—Decreased appetite—Leflunomide—systemic scleroderma	0.000777	0.00153	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000776	0.00153	CcSEcCtD
Amiloride—Confusional state—Lisinopril—systemic scleroderma	0.000774	0.00153	CcSEcCtD
Amiloride—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000774	0.00153	CcSEcCtD
Amiloride—Headache—Mometasone—systemic scleroderma	0.000773	0.00153	CcSEcCtD
Amiloride—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000772	0.00152	CcSEcCtD
Amiloride—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000771	0.00152	CcSEcCtD
Amiloride—Insomnia—Mycophenolic acid—systemic scleroderma	0.000771	0.00152	CcSEcCtD
Amiloride—Fatigue—Leflunomide—systemic scleroderma	0.00077	0.00152	CcSEcCtD
Amiloride—Pruritus—Captopril—systemic scleroderma	0.000767	0.00151	CcSEcCtD
Amiloride—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000765	0.00151	CcSEcCtD
Amiloride—Constipation—Leflunomide—systemic scleroderma	0.000764	0.00151	CcSEcCtD
Amiloride—Pain—Leflunomide—systemic scleroderma	0.000764	0.00151	CcSEcCtD
Amiloride—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00076	0.0015	CcSEcCtD
Amiloride—Somnolence—Mycophenolic acid—systemic scleroderma	0.000758	0.00149	CcSEcCtD
Amiloride—Shock—Lisinopril—systemic scleroderma	0.000755	0.00149	CcSEcCtD
Amiloride—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00075	0.00148	CcSEcCtD
Amiloride—Neutropenia—Prednisone—systemic scleroderma	0.00075	0.00148	CcSEcCtD
Amiloride—Abdominal pain—Azathioprine—systemic scleroderma	0.000748	0.00148	CcSEcCtD
Amiloride—Diarrhoea—Captopril—systemic scleroderma	0.000742	0.00146	CcSEcCtD
Amiloride—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000741	0.00146	CcSEcCtD
Amiloride—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00146	CcSEcCtD
Amiloride—Erectile dysfunction—Prednisone—systemic scleroderma	0.000738	0.00146	CcSEcCtD
Amiloride—Feeling abnormal—Leflunomide—systemic scleroderma	0.000736	0.00145	CcSEcCtD
Amiloride—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000736	0.00145	CcSEcCtD
Amiloride—Fatigue—Mycophenolic acid—systemic scleroderma	0.000735	0.00145	CcSEcCtD
Amiloride—Nausea—Mometasone—systemic scleroderma	0.000733	0.00145	CcSEcCtD
Amiloride—Anorexia—Lisinopril—systemic scleroderma	0.000732	0.00144	CcSEcCtD
Amiloride—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00073	0.00144	CcSEcCtD
Amiloride—Constipation—Mycophenolic acid—systemic scleroderma	0.000729	0.00144	CcSEcCtD
Amiloride—Pain—Mycophenolic acid—systemic scleroderma	0.000729	0.00144	CcSEcCtD
Amiloride—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000728	0.00144	CcSEcCtD
Amiloride—Cough—Mycophenolate mofetil—systemic scleroderma	0.000719	0.00142	CcSEcCtD
Amiloride—Dizziness—Captopril—systemic scleroderma	0.000717	0.00141	CcSEcCtD
Amiloride—Depression—Prednisone—systemic scleroderma	0.000713	0.00141	CcSEcCtD
Amiloride—Abdominal pain—Leflunomide—systemic scleroderma	0.000706	0.00139	CcSEcCtD
Amiloride—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000702	0.00139	CcSEcCtD
Amiloride—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00138	CcSEcCtD
Amiloride—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00138	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000699	0.00138	CcSEcCtD
Amiloride—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000697	0.00138	CcSEcCtD
Amiloride—Insomnia—Lisinopril—systemic scleroderma	0.000694	0.00137	CcSEcCtD
Amiloride—Paraesthesia—Lisinopril—systemic scleroderma	0.000689	0.00136	CcSEcCtD
Amiloride—Vomiting—Captopril—systemic scleroderma	0.000689	0.00136	CcSEcCtD
Amiloride—Dyspnoea—Lisinopril—systemic scleroderma	0.000684	0.00135	CcSEcCtD
Amiloride—Rash—Captopril—systemic scleroderma	0.000683	0.00135	CcSEcCtD
Amiloride—Dermatitis—Captopril—systemic scleroderma	0.000683	0.00135	CcSEcCtD
Amiloride—Somnolence—Lisinopril—systemic scleroderma	0.000682	0.00135	CcSEcCtD
Amiloride—Headache—Captopril—systemic scleroderma	0.000679	0.00134	CcSEcCtD
Amiloride—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00134	CcSEcCtD
Amiloride—Dyspepsia—Lisinopril—systemic scleroderma	0.000676	0.00133	CcSEcCtD
Amiloride—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000674	0.00133	CcSEcCtD
Amiloride—Decreased appetite—Lisinopril—systemic scleroderma	0.000667	0.00132	CcSEcCtD
Amiloride—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000663	0.00131	CcSEcCtD
Amiloride—Fatigue—Lisinopril—systemic scleroderma	0.000662	0.00131	CcSEcCtD
Amiloride—Shock—Mycophenolate mofetil—systemic scleroderma	0.000662	0.00131	CcSEcCtD
Amiloride—Pain—Lisinopril—systemic scleroderma	0.000656	0.0013	CcSEcCtD
Amiloride—Constipation—Lisinopril—systemic scleroderma	0.000656	0.0013	CcSEcCtD
Amiloride—Bradycardia—Prednisone—systemic scleroderma	0.000653	0.00129	CcSEcCtD
Amiloride—Diarrhoea—Azathioprine—systemic scleroderma	0.000647	0.00128	CcSEcCtD
Amiloride—Haemoglobin—Prednisone—systemic scleroderma	0.000645	0.00127	CcSEcCtD
Amiloride—Nausea—Captopril—systemic scleroderma	0.000644	0.00127	CcSEcCtD
Amiloride—Haemorrhage—Prednisone—systemic scleroderma	0.000642	0.00127	CcSEcCtD
Amiloride—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000641	0.00126	CcSEcCtD
Amiloride—Asthenia—Leflunomide—systemic scleroderma	0.000641	0.00126	CcSEcCtD
Amiloride—SLC9A1—Disease—HSPG2—systemic scleroderma	0.000636	0.00238	CbGpPWpGaD
Amiloride—Feeling abnormal—Lisinopril—systemic scleroderma	0.000633	0.00125	CcSEcCtD
Amiloride—Pruritus—Leflunomide—systemic scleroderma	0.000632	0.00125	CcSEcCtD
Amiloride—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000628	0.00124	CcSEcCtD
Amiloride—Neutropenia—Methotrexate—systemic scleroderma	0.000626	0.00124	CcSEcCtD
Amiloride—Dysuria—Methotrexate—systemic scleroderma	0.000626	0.00124	CcSEcCtD
Amiloride—Dizziness—Azathioprine—systemic scleroderma	0.000626	0.00123	CcSEcCtD
Amiloride—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000617	0.00122	CcSEcCtD
Amiloride—SLC9A1—Disease—CSK—systemic scleroderma	0.000614	0.0023	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000613	0.00121	CcSEcCtD
Amiloride—Asthenia—Mycophenolic acid—systemic scleroderma	0.000611	0.00121	CcSEcCtD
Amiloride—Diarrhoea—Leflunomide—systemic scleroderma	0.000611	0.00121	CcSEcCtD
Amiloride—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000608	0.0012	CcSEcCtD
Amiloride—Abdominal pain—Lisinopril—systemic scleroderma	0.000607	0.0012	CcSEcCtD
Amiloride—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000604	0.00119	CcSEcCtD
Amiloride—Pruritus—Mycophenolic acid—systemic scleroderma	0.000603	0.00119	CcSEcCtD
Amiloride—Vomiting—Azathioprine—systemic scleroderma	0.000601	0.00119	CcSEcCtD
Amiloride—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.0006	0.00118	CcSEcCtD
Amiloride—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000598	0.00118	CcSEcCtD
Amiloride—Rash—Azathioprine—systemic scleroderma	0.000596	0.00118	CcSEcCtD
Amiloride—Dermatitis—Azathioprine—systemic scleroderma	0.000596	0.00118	CcSEcCtD
Amiloride—Depression—Methotrexate—systemic scleroderma	0.000596	0.00118	CcSEcCtD
Amiloride—Headache—Azathioprine—systemic scleroderma	0.000593	0.00117	CcSEcCtD
Amiloride—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000592	0.00117	CcSEcCtD
Amiloride—Dizziness—Leflunomide—systemic scleroderma	0.000591	0.00117	CcSEcCtD
Amiloride—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00115	CcSEcCtD
Amiloride—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000583	0.00115	CcSEcCtD
Amiloride—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000581	0.00115	CcSEcCtD
Amiloride—SLC9A1—Disease—CD247—systemic scleroderma	0.000577	0.00216	CbGpPWpGaD
Amiloride—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000575	0.00113	CcSEcCtD
Amiloride—Pain—Mycophenolate mofetil—systemic scleroderma	0.000575	0.00113	CcSEcCtD
Amiloride—Vomiting—Leflunomide—systemic scleroderma	0.000568	0.00112	CcSEcCtD
Amiloride—Alopecia—Prednisone—systemic scleroderma	0.000567	0.00112	CcSEcCtD
Amiloride—Dizziness—Mycophenolic acid—systemic scleroderma	0.000564	0.00111	CcSEcCtD
Amiloride—Rash—Leflunomide—systemic scleroderma	0.000563	0.00111	CcSEcCtD
Amiloride—Dermatitis—Leflunomide—systemic scleroderma	0.000563	0.00111	CcSEcCtD
Amiloride—Nausea—Azathioprine—systemic scleroderma	0.000562	0.00111	CcSEcCtD
Amiloride—Headache—Leflunomide—systemic scleroderma	0.00056	0.0011	CcSEcCtD
Amiloride—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000554	0.00109	CcSEcCtD
Amiloride—Asthenia—Lisinopril—systemic scleroderma	0.000551	0.00109	CcSEcCtD
Amiloride—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00109	CcSEcCtD
Amiloride—Pruritus—Lisinopril—systemic scleroderma	0.000543	0.00107	CcSEcCtD
Amiloride—Vomiting—Mycophenolic acid—systemic scleroderma	0.000542	0.00107	CcSEcCtD
Amiloride—PLAU—Hemostasis—MMP1—systemic scleroderma	0.000539	0.00202	CbGpPWpGaD
Amiloride—Haemoglobin—Methotrexate—systemic scleroderma	0.000539	0.00106	CcSEcCtD
Amiloride—Rash—Mycophenolic acid—systemic scleroderma	0.000537	0.00106	CcSEcCtD
Amiloride—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000537	0.00106	CcSEcCtD
Amiloride—Haemorrhage—Methotrexate—systemic scleroderma	0.000536	0.00106	CcSEcCtD
Amiloride—Headache—Mycophenolic acid—systemic scleroderma	0.000534	0.00105	CcSEcCtD
Amiloride—SLC9A1—Metabolism—HSPG2—systemic scleroderma	0.000533	0.002	CbGpPWpGaD
Amiloride—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000532	0.00105	CcSEcCtD
Amiloride—Nausea—Leflunomide—systemic scleroderma	0.000531	0.00105	CcSEcCtD
Amiloride—Diarrhoea—Lisinopril—systemic scleroderma	0.000525	0.00104	CcSEcCtD
Amiloride—Visual impairment—Methotrexate—systemic scleroderma	0.000517	0.00102	CcSEcCtD
Amiloride—Dizziness—Lisinopril—systemic scleroderma	0.000508	0.001	CcSEcCtD
Amiloride—Nausea—Mycophenolic acid—systemic scleroderma	0.000506	0.000999	CcSEcCtD
Amiloride—Vertigo—Prednisone—systemic scleroderma	0.000502	0.00099	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—systemic scleroderma	0.0005	0.000987	CcSEcCtD
Amiloride—Vomiting—Lisinopril—systemic scleroderma	0.000488	0.000963	CcSEcCtD
Amiloride—Rash—Lisinopril—systemic scleroderma	0.000484	0.000955	CcSEcCtD
Amiloride—Dermatitis—Lisinopril—systemic scleroderma	0.000484	0.000954	CcSEcCtD
Amiloride—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000952	CcSEcCtD
Amiloride—Headache—Lisinopril—systemic scleroderma	0.000481	0.000949	CcSEcCtD
Amiloride—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000476	0.000939	CcSEcCtD
Amiloride—Arthralgia—Prednisone—systemic scleroderma	0.000476	0.000938	CcSEcCtD
Amiloride—Alopecia—Methotrexate—systemic scleroderma	0.000474	0.000935	CcSEcCtD
Amiloride—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00046	0.000908	CcSEcCtD
Amiloride—Nausea—Lisinopril—systemic scleroderma	0.000456	0.0009	CcSEcCtD
Amiloride—Back pain—Methotrexate—systemic scleroderma	0.000452	0.000891	CcSEcCtD
Amiloride—Shock—Prednisone—systemic scleroderma	0.000449	0.000885	CcSEcCtD
Amiloride—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000445	0.000878	CcSEcCtD
Amiloride—Anorexia—Prednisone—systemic scleroderma	0.000435	0.000857	CcSEcCtD
Amiloride—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000844	CcSEcCtD
Amiloride—Rash—Mycophenolate mofetil—systemic scleroderma	0.000424	0.000837	CcSEcCtD
Amiloride—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000424	0.000836	CcSEcCtD
Amiloride—Headache—Mycophenolate mofetil—systemic scleroderma	0.000421	0.000831	CcSEcCtD
Amiloride—Vertigo—Methotrexate—systemic scleroderma	0.000419	0.000828	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000415	0.00082	CcSEcCtD
Amiloride—Insomnia—Prednisone—systemic scleroderma	0.000412	0.000814	CcSEcCtD
Amiloride—Paraesthesia—Prednisone—systemic scleroderma	0.000409	0.000808	CcSEcCtD
Amiloride—Cough—Methotrexate—systemic scleroderma	0.000407	0.000804	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CTGF—systemic scleroderma	0.000404	0.00151	CbGpPWpGaD
Amiloride—Dyspepsia—Prednisone—systemic scleroderma	0.000401	0.000792	CcSEcCtD
Amiloride—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000399	0.000788	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—systemic scleroderma	0.000397	0.000784	CcSEcCtD
Amiloride—Chest pain—Methotrexate—systemic scleroderma	0.000397	0.000784	CcSEcCtD
Amiloride—Decreased appetite—Prednisone—systemic scleroderma	0.000396	0.000782	CcSEcCtD
Amiloride—Fatigue—Prednisone—systemic scleroderma	0.000393	0.000776	CcSEcCtD
Amiloride—PLAU—Hemostasis—NOS3—systemic scleroderma	0.000391	0.00146	CbGpPWpGaD
Amiloride—Constipation—Prednisone—systemic scleroderma	0.00039	0.000769	CcSEcCtD
Amiloride—Confusional state—Methotrexate—systemic scleroderma	0.000384	0.000758	CcSEcCtD
Amiloride—Feeling abnormal—Prednisone—systemic scleroderma	0.000376	0.000741	CcSEcCtD
Amiloride—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000373	0.000736	CcSEcCtD
Amiloride—Anorexia—Methotrexate—systemic scleroderma	0.000363	0.000717	CcSEcCtD
Amiloride—Abdominal pain—Prednisone—systemic scleroderma	0.00036	0.000711	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000347	0.000685	CcSEcCtD
Amiloride—Insomnia—Methotrexate—systemic scleroderma	0.000345	0.00068	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—systemic scleroderma	0.000342	0.000675	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—systemic scleroderma	0.00034	0.00067	CcSEcCtD
Amiloride—Somnolence—Methotrexate—systemic scleroderma	0.000339	0.000668	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—systemic scleroderma	0.000335	0.000662	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—systemic scleroderma	0.000331	0.000654	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000329	0.000649	CcSEcCtD
Amiloride—Fatigue—Methotrexate—systemic scleroderma	0.000328	0.000648	CcSEcCtD
Amiloride—Asthenia—Prednisone—systemic scleroderma	0.000327	0.000645	CcSEcCtD
Amiloride—Pain—Methotrexate—systemic scleroderma	0.000326	0.000643	CcSEcCtD
Amiloride—Pruritus—Prednisone—systemic scleroderma	0.000323	0.000636	CcSEcCtD
Amiloride—Feeling abnormal—Methotrexate—systemic scleroderma	0.000314	0.000619	CcSEcCtD
Amiloride—Diarrhoea—Prednisone—systemic scleroderma	0.000312	0.000615	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000312	0.000615	CcSEcCtD
Amiloride—Dizziness—Prednisone—systemic scleroderma	0.000301	0.000595	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—systemic scleroderma	0.000301	0.000594	CcSEcCtD
Amiloride—Vomiting—Prednisone—systemic scleroderma	0.00029	0.000572	CcSEcCtD
Amiloride—Rash—Prednisone—systemic scleroderma	0.000287	0.000567	CcSEcCtD
Amiloride—Dermatitis—Prednisone—systemic scleroderma	0.000287	0.000567	CcSEcCtD
Amiloride—Headache—Prednisone—systemic scleroderma	0.000286	0.000564	CcSEcCtD
Amiloride—Asthenia—Methotrexate—systemic scleroderma	0.000273	0.000539	CcSEcCtD
Amiloride—Nausea—Prednisone—systemic scleroderma	0.000271	0.000534	CcSEcCtD
Amiloride—Pruritus—Methotrexate—systemic scleroderma	0.00027	0.000532	CcSEcCtD
Amiloride—Diarrhoea—Methotrexate—systemic scleroderma	0.000261	0.000514	CcSEcCtD
Amiloride—PLAU—Hemostasis—TGFB1—systemic scleroderma	0.000258	0.000969	CbGpPWpGaD
Amiloride—Dizziness—Methotrexate—systemic scleroderma	0.000252	0.000497	CcSEcCtD
Amiloride—Vomiting—Methotrexate—systemic scleroderma	0.000242	0.000478	CcSEcCtD
Amiloride—Rash—Methotrexate—systemic scleroderma	0.00024	0.000474	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—systemic scleroderma	0.00024	0.000474	CcSEcCtD
Amiloride—Headache—Methotrexate—systemic scleroderma	0.000239	0.000471	CcSEcCtD
Amiloride—Nausea—Methotrexate—systemic scleroderma	0.000226	0.000447	CcSEcCtD
Amiloride—SLC9A1—Disease—NOS3—systemic scleroderma	0.00021	0.000786	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—systemic scleroderma	0.000176	0.000658	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—systemic scleroderma	0.000139	0.00052	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSPG2—systemic scleroderma	0.000115	0.000432	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSPG2—systemic scleroderma	0.000107	0.000403	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CTGF—systemic scleroderma	8.74e-05	0.000327	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CTGF—systemic scleroderma	8.14e-05	0.000305	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—systemic scleroderma	3.8e-05	0.000143	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—systemic scleroderma	3.54e-05	0.000133	CbGpPWpGaD
